HJGA
TEVA icon

Hardman Johnston Global Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Hardman Johnston Global Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-95,205
Closed -$3.6M – 80
2013
Q3 		$3.6M Buy
95,205
+27,766
+41% +$1.08M 0.24% 50
2013
Q2 		$2.64M Buy
+67,439
New +$2.63M 0.18% 54

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hardman Johnston Global Advisors's TEVA Position: Q4 2013 in Review

Hardman Johnston Global Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2013, closing a stake of 95,205 shares — an estimated $3.6M sold.

Hardman Johnston Global Advisors first reported a position in TEVA in Q2 2013 and held it in 2 quarters. The position peaked at $3.6M in Q3 2013. 728 funds tracked by Wall St. Rank hold TEVA as of Q4 2013.

  • Hardman Johnston Global Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2013 after selling out during the quarter.
  • Hardman Johnston Global Advisors sold 95,205 Teva Pharmaceutical Industries Limited shares in Q4 2013, an estimated $3.6M.
  • Hardman Johnston Global Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 2 quarters.
  • Hardman Johnston Global Advisors's Teva Pharmaceutical Industries Limited position peaked at $3.6M in Q3 2013.
  • 728 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2013.

Based on Hardman Johnston Global Advisors's 13F filing for Q4 2013, filed 10 Feb 2014.